PWA
CORT icon

Physician Wealth Advisors’s Corcept Therapeutics CORT Stock Holding History

Physician Wealth Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522 Buy
+6
New +$362 ﹤0.01% 2107
2026
Q1 		– Sell
-16
Closed -$557 – 2097
2025
Q4 		$557 Hold
16
– – ﹤0.01% 1828
2025
Q3 		$1.33K Hold
16
– – ﹤0.01% 1410
2025
Q2 		$1.18K Buy
+16
New +$1.16K ﹤0.01% 1287

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Physician Wealth Advisors's CORT Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 6 shares worth $522. The stake represents ﹤0.01% of the portfolio and ranks #2107 among its holdings. This is a return to the name: Physician Wealth Advisors previously reported a position in CORT as recently as Q4 2025.

Physician Wealth Advisors first reported a position in CORT in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.33K in Q3 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Physician Wealth Advisors held 6 shares of Corcept Therapeutics worth $522 as of Q2 2026.
  • Corcept Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2107 holding.
  • Physician Wealth Advisors first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Physician Wealth Advisors's Corcept Therapeutics position peaked at $1.33K in Q3 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.